PTCH1: NEW TARGET FOR MONITORING CHRONIC MYELOID LEUKAEMIA AND THERAPY

被引:0
|
作者
Cirmena, G. [1 ]
Cea, M. [1 ]
Garuti, A. [1 ]
Rocco, I. [1 ]
Palermo, C. [1 ]
Carella, A. M. [2 ]
Patrone, F. [1 ]
Ballestrero, A. [1 ]
机构
[1] Univ Genoa, Genoa, Italy
[2] Azienda Ospedaliera Univ San Martino, Div Hematol, Genoa, Italy
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0127
引用
收藏
页码:50 / 51
页数:2
相关论文
共 50 条
  • [1] PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase
    Alonso-Dominguez, Juan M.
    Grinfeld, Jacob
    Alikian, Mary
    Marin, David
    Reid, Alistair
    Daghistani, Mustafa
    Hedgley, Corinne
    O'Brien, Stephen
    Clark, Richard E.
    Apperley, Jane
    Foroni, Letizia
    Gerrard, Gareth
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (01) : 20 - 26
  • [2] PTCH1 Expression At Diagnosis Reliably Predicts Treatment Failure in Imatinib-Treated Chronic Myeloid Leukaemia Patients
    Alonso-Dominguez, Juan M.
    Grinfeld, Jacob
    Alikian, Mary
    Marin, David
    Reid, Alistair
    Daghistani, Mustafa
    Apperley, Jane
    Goldman, John M.
    Hedgley, Corinne
    O'Brien, Steve
    Clark, Richard E.
    Foroni, Letizia
    Gerrard, Gareth
    BLOOD, 2012, 120 (21)
  • [3] TRANSCRIPT LEVELS OF THE HEDGEHOG PATHWAY MEMBERS PTCH1 AND SMO ARE PREDICTIVE OF IMATINIB FAILURE IN PRE-TREATMENT CHRONIC MYELOID LEUKAEMIA
    Gerrard, G.
    Hagkarim, N. C.
    Szydlo, R.
    Alikian, M.
    Alonso-Dominguez, J. M.
    Grinfeld, J.
    Hedgley, C.
    O'Brien, S.
    Clark, R. E.
    Apperley, J.
    Foroni, L.
    HAEMATOLOGICA, 2014, 99 : 510 - 510
  • [4] PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase
    Alonso-Dominguez, Juan M.
    Felipe Casado, Luis
    Anguita, Eduardo
    Teresa Gomez-Casares, Maria
    Buno, Ismael
    Ferrer-Marin, Francisca
    Arenas, Alicia
    Del Orbe, Rafael
    Ayala, Rosa
    Llamas, Pilar
    Salgado, Rocio N.
    Osorio, Santiago
    Sanchez-Godoy, Pedro
    Burgaleta, Carmen
    Mahillo-Fernandez, Ignacio
    Garcia-Gutierrez, Valentin
    Luis Steegmann, Juan
    Martinez-Lopez, Joaquin
    PLOS ONE, 2017, 12 (07):
  • [5] The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia
    Lebecque, Benjamin
    Bourgne, Celine
    Munje, Chinmay
    Berger, Juliette
    Tassin, Thomas
    Cony-Makhoul, Pascale
    Guerci-Bresler, Agnes
    Johnson-Ansah, Hyacinthe
    Liu, Wei
    Saugues, Sandrine
    Tchirkov, Andrei
    Vetrie, David
    Copland, Mhairi
    Berger, Marc G.
    CANCERS, 2022, 14 (19)
  • [6] Human neutrophil elastase is not a target for therapy in chronic myeloid leukaemia
    E K Allan
    T L Holyoake
    H G Jørgensen
    Leukemia, 2006, 20 : 2054 - 2055
  • [7] Human neutrophil elastase is not a target for therapy in chronic myeloid leukaemia
    Allan, E. K.
    Holyoake, T. L.
    Jorgensen, H. G.
    LEUKEMIA, 2006, 20 (11) : 2054 - 2055
  • [8] DETERMINATION OF THE EFFECTORS OF THE HEDGEHOG ROUTE AND THE EFFECT OF THE TYROSINE KINASE INHIBITORS ON THE EXPRESSION OF PTCH1 IN CHRONIC MYELOID LEUKEMIA
    Arenas, A.
    Llamas, P.
    Blas, C.
    Garcia-Raso, A.
    Lopez Lorenzo, J. L.
    Atance, M.
    Salgado, R.
    Martinez-Lopez, J.
    Alonso-Dominguez, J. M.
    HAEMATOLOGICA, 2018, 103 : 211 - 211
  • [9] Measurement of PTCH1 Expression at Diagnosis Is an Appropriate Tool for Tyrosine Kinase Inhibitors Selection in Chronic Myeloid Leukemia Patients in Chronic Phase
    Manuel Alonso-Dominguez, Juan
    Casado, Felipe
    Gomez Casares, MariaTeresa
    Buno, Ismael
    Ferrer-Marin, Francisca
    Anguita, Eduardo
    Arenas, Alicia
    Del Orbe, Rafael
    Ayala, Rosa M.
    Llamas, Pilar
    Sanchez-Godoy, Pedro
    Burgaleta, Carmen
    Garcia-Gutierrez, Valentin
    Luis Steegmann, Juan
    Martinez-Lopez, Joaquin
    BLOOD, 2015, 126 (23)
  • [10] Is human neutrophil elastase activity in chronic myeloid leukaemia a potential target for therapy?
    Allan, EK
    Stewart, K
    Holyoake, TL
    Jorgensen, HG
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 105 - 105